The challenges of viral pneumonia in the post-COVID era

C. García-Vidal (Barcelona, Spain)

Source: Virtual Congress 2021 – Community-acquired pneumonia: the new perspective in the post-COVID era
Session: Community-acquired pneumonia: the new perspective in the post-COVID era
Session type: Symposium
Number: 4105

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. García-Vidal (Barcelona, Spain). The challenges of viral pneumonia in the post-COVID era. Virtual Congress 2021 – Community-acquired pneumonia: the new perspective in the post-COVID era

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary infections in HIV-infected patients: an update in the 21st century
Source: Eur Respir J 2012; 39: 730-745
Year: 2012



Challenges in understanding host genetics and severity of community-acquired pneumonia
Source: ERJ Open Res, 7 (1) 00745-2020; 10.1183/23120541.00745-2020
Year: 2021



Management of an infectious outbreak in the modern era
Source: Lung Science Conference 2015
Year: 2015




Update on management of new emerging acute respiratory viral infectious diseases
Source: International Congress 2018 – Chinese Programme 2018: Part I
Year: 2018


PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice
Source: Milan 2017 - Educational material
Year: 2017

Development of paediatric asthma following viral infections
Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease
Year: 2021


Virological diagnosis in community-acquired pneumonia in immunocompromised patients
Source: Eur Respir J 2008; 31: 618-624
Year: 2008



Human metapneumovirus and community-acquired pneumonia: a pediatric survey
Source: Annual Congress 2005 - New insights in respiratory infections in children
Year: 2005


Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021


Economic aspects of enhanced testing strategies for respiratory diseases
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021

Interactions between bacterial and viral infections during COPD exacerbations: implications for prevention strategies
Source: International Congress 2019 – Scientific Year in review
Year: 2019


Features of the clinical course of coronavirus and bacterial pneumonia
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021


Promising prophylactic means and methods for prevention of community-acquired pneumonia and respiratory infections among servicemen in Russia
Source: Eur Respir J 2006; 28: Suppl. 50, 350s
Year: 2006

Widespread use of face masks and respiratory viral infections: the SARS-CoV-2 pandemic lesson
Source: Virtual Congress 2021 – Acute and chronic lung infections in children
Year: 2021



Update on therapeutic strategies in community-acquired pneumonia   
Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice
Year: 2017


The severity of Pneumocystis pneumonia without human immunodeficiency virus infection (non-HIV PCP) might be underestimated by conventional diagnostic rules for community-acquired pneumonia (CAP)
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010

Update on preventing and managing hospital-acquired and ventilatory-associated pneumonia
Source: International Congress 2019 – State of the art session: Respiratory infections
Year: 2019


Advances in the diagnosis of mycobacteria infections and challenges of drug susceptibility testing
Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease
Year: 2019


Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia
Source: Annual Congress 2007 - Infections year in review
Year: 2007